| Target Price | $7.14 |
| Price | $1.11 |
| Potential |
543.24%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Compass Therapeutics 2027 .
The average Compass Therapeutics target price is $7.14.
This is
543.24%
register free of charge
$25.20
2,170.27%
register free of charge
$5.05
354.95%
register free of charge
|
|
| A rating was issued by 21 analysts: 19 Analysts recommend Compass Therapeutics to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Compass Therapeutics stock has an average upside potential 2027 of
543.24%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Apr 28 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Apr 28 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


